Irinotecan Discontinuation and Reintroduction for Advanced Colorectal Cancer
Status:
Terminated
Trial end date:
2007-04-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the feasibility and efficacy of first-line FOLFIRI
discontinuation after initial 8 cycles and reintroduction after progression.